Conduit Pharmaceuticals partners with Charles River to evaluate AZD1656 for lupus, enhancing preclinical research and improving Phase II trial success. Conduit Pharmaceuticals has announced a ...

BOSTON--(BUSINESS WIRE)-- Charles River Development, a State Street Company, announced today the expansion of its relationship with T. Rowe Price through the migration to the SaaS-deployed Charles ...

BOSTON--(BUSINESS WIRE)--Charles River Development, a State Street Company, announced today that Operadora de Fondos Banorte, SA de CV, SOFI, Grupo Financiero Banorte ("BANORTE"), one of Mexico’s ...

Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and Approximately $0.60 in 2027 –– Exercises Option to ...

Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and ...

BOSTON--(BUSINESS WIRE)--Charles River Development, a State Street Company, announced today that T. Rowe Price will transition to Charles River’s cloud-based technology platform. T. Rowe Price will ...

State Street Company Charles River Development has launched Tailored Portfolio Solutions (TPS), an offering that enables both wealth managers and asset managers to provide customised portfolios at ...